P Biswas

Summary

Affiliation: Drug Safety Research Unit
Country: UK

Publications

  1. ncbi request reprint Troglitazone and liver function abnormalities: lessons from a prescription event monitoring study and spontaneous reporting
    P Biswas
    Drug Safety Research Unit, Southampton, England
    Drug Saf 24:149-54. 2001
  2. ncbi request reprint The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England
    P N Biswasl
    Drug Safety Research Unit, Faculty of Health and Biological Sciences, University of Southampton, UK
    J Psychopharmacol 15:265-71. 2001
  3. ncbi request reprint Montelukast and improvement of eczema: observations from a prescription event monitoring study in England
    P Biswas
    Drug Safety Research Unit, Southampton, Hants, UK
    Int J Clin Pharmacol Ther 39:529-33. 2001
  4. ncbi request reprint The safety of valsartan: results of a postmarketing surveillance study on 12881 patients in England
    P N Biswas
    Drug Safety Research Unit, Bursledon Hall, Southampton SO31 1AA, UK
    J Hum Hypertens 16:795-803. 2002
  5. ncbi request reprint The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England
    Pipasha N Biswas
    Drug Safety Research Unit, Bursledon Hall, Southampton, London, UK
    J Psychopharmacol 17:121-6. 2003

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Troglitazone and liver function abnormalities: lessons from a prescription event monitoring study and spontaneous reporting
    P Biswas
    Drug Safety Research Unit, Southampton, England
    Drug Saf 24:149-54. 2001
    ..To investigate whether there were any cases of liver function abnormalities possibly associated with troglitazone use in general practice in England...
  2. ncbi request reprint The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England
    P N Biswasl
    Drug Safety Research Unit, Faculty of Health and Biological Sciences, University of Southampton, UK
    J Psychopharmacol 15:265-71. 2001
    ..There were eight reports of diabetes mellitus assessed as possibly due to olanzapine. Diabetes mellitus was an unlabelled AE and possible signal generated by prescription-event monitoring...
  3. ncbi request reprint Montelukast and improvement of eczema: observations from a prescription event monitoring study in England
    P Biswas
    Drug Safety Research Unit, Southampton, Hants, UK
    Int J Clin Pharmacol Ther 39:529-33. 2001
    ..The objective of this study was to determine whether there are any beneficial effects of montelukast on eczema and urticaria...
  4. ncbi request reprint The safety of valsartan: results of a postmarketing surveillance study on 12881 patients in England
    P N Biswas
    Drug Safety Research Unit, Bursledon Hall, Southampton SO31 1AA, UK
    J Hum Hypertens 16:795-803. 2002
    ..No untoward features other than dizziness were identified that were not mentioned in the prescribing guidance...
  5. ncbi request reprint The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England
    Pipasha N Biswas
    Drug Safety Research Unit, Bursledon Hall, Southampton, London, UK
    J Psychopharmacol 17:121-6. 2003
    ..Serious suspected ADRs reported were facial oedema (5), allergy (3), bone marrow toxicity (2) and myelodysplasia (1)...